Bioline Rx Revenue Quarterly:
0.00 for March 31, 2013Bioline Rx Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.00 |
| Dec. 31, 2012 | 0.00 |
| Sept. 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| Dec. 31, 2011 | 0.00 |
| Sept. 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | 0.00 |
| Sept. 30, 2010 | 30.89M |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
BLRX Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Array BioPharma | 9.955M |
| Cytokinetics | 0.821M |
| Oramed Pharmaceuticals | 0.00 |
BLRX Revenue Quarterly Rankings
| Overall |
36th percentile 5050 of 8002 |
| Sector |
20th percentile 545 of 684 in Healthcare |
| Industry |
33rd percentile 165 of 248 in Biotechnology |
BLRX Revenue Quarterly Range, Past 5 Years
| Minimum | 0.00 | Mar 2010 |
| Maximum | 30.89M | Sep 2010 |
| Average | 2.376M |
BLRX News
BioLineRx (BLRX) Enrolls First Patients in BL-8020 Phase I/II as HCV Treatment
Street Insider Apr 29
Street Insider Apr 29
